Product Information
FETZIMA ER 80 MG CAPSULE is a brand product labeled by Allergan, Inc., priced at $17.5900 per EA under NDC 00456228030. Its NADAC has been published 649 times since Mar 19, 2014.
FDA first approved this application on Jul 25, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
80 mg/1
Manufacturer
Allergan, Inc.NDC
00456228030
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LEVOMILNACIPRAN HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA204168FDA Approved
7/25/2013
TE Code
AB
On Market Since
7/25/2013
Pharmacological Classes
Price Statistics
The NADAC for FETZIMA ER 80 MG CAPSULE has been published 649 times since Mar 19, 2014, and over the history we have for it it has risen 170.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $17.5900 per EA |
|---|---|
| All-time high | $17.6471 (May 13, 2026) |
| All-time low | $6.4922 (Mar 19, 2014) |
| 52-week high | $17.6471 |
| 52-week low | $16.8006 |
| Median price | $13.1597 |
| Average price | $12.7249 |
| Largest weekly change | +16.9% (Oct 8, 2014) |
| Weeks tracked | 649 |
| Tracking since | Mar 19, 2014 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the LEVOMILNACIPRAN HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FETZIMA ER 80 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for FETZIMA ER 80 MG CAPSULE, manufactured by Allergan, Inc., is $17.5900 per EA (NDC 00456228030), effective Aug 19, 2026.
How has the price of FETZIMA ER 80 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for FETZIMA ER 80 MG CAPSULE has risen 170.9%. It has been tracked across 649 weekly CMS publications since Mar 19, 2014.
What are the highest and lowest recorded NADAC prices for FETZIMA ER 80 MG CAPSULE?
Since Mar 19, 2014, the NADAC for FETZIMA ER 80 MG CAPSULE has ranged from a low of $6.4922 (Mar 19, 2014) to a high of $17.6471 (May 13, 2026), with a median of $13.1597 per EA.
Are there cheaper alternatives to FETZIMA ER 80 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of FETZIMA ER 80 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FETZIMA ER 80 MG CAPSULE?
FETZIMA ER 80 MG CAPSULE (NDC 00456228030) is labeled by Allergan, Inc., and CMS classifies it as a brand product.